Stock Learning

LEIDEN, NETHERLANDS--(Marketwire - March 15, 2010) -

LEIDEN, NETHERLANDS--(Marketwire - March 15, 2010) -

MARTINSRIED, GERMANY--(Marketwire - March 15, 2010) -

GHENT, BELGIUM--(Marketwire - March 15, 2010) -

LAKE FOREST, CA--(Marketwire - March 12, 2010) -  CryoPort, Inc. (OTCBB: CYRXD), today announced that effective as of the opening of trading on Monday, March 15, 2010, CryoPort's ticker symbol for its common stock will revert back to "CYRX" (OTCBB: CYRX). As a result of the Company's one-for-ten reverse stock split which became effective February 5, 2010, the Company's common stock had been trading on a post-split basis under the temporary trading symbol "CYRXD" for approximately 20 trading days.

TORONTO--(Marketwire - March 12, 2010) -  The Ontario Institute for Cancer Research (OICR) today announced a significant investment toward the development of two new promising cancer therapies. The recipients of the awards are:

GTT Offers 1st & Only Worldwide Live In-Country Telephone Number Testing & Monitoring Ensuring Customer Retention

LAS VEGAS, NV--(Marketwire - March 12, 2010) -  Alfred T. Sapse MD of Endogenous Stem Cells Activators, Inc. released a statement today:

SANTA BARBARA, CA--(Marketwire - March 12, 2010) -  Wiley SystemsT, Inc., developer of the Wiley Protocol biomimetic rhythmic hormones, announced today that its Pharmacist in Charge Dana Nelson received the Compounding Pharmacist of the Year award from The California Pharmacists Association (CPhA). Nelson is also a pharmacy owner from San Luis Obispo, CA. In 2009 he also won the award for the Innovative Practice Site. 

New Features Enhance Ease of Use in Noninvasive Central Blood Pressure Assessment

SAN JOSE, CA--(Marketwire - March 12, 2010) -  DeCarolis Design & Marketing, a full service agency headquartered in San Jose, CA, has been awarded a Gold level ADDY^® Award by the Silicon Valley Chapter of the American Advertising Federation (AAF). The creative team at DeCarolis won the gold for its graphic design for Fine Science Tools, a producer of precision tools for scientific research. Graphic Designer James Reed created the design for the ad campaign aimed at conveying the quality and precision of the product.

I-many Solution Chosen to Manage Top Pharmaceutical Company's North American Contract Management and Managed Care Contracting Operations

Paul Fitzpatrick Excels With Early Stage Medical Device Companies

Selection Ranges From Early- to Mid-Stage Companies Seeking Investment

STOCKHOLM, SWEDEN--(Marketwire - March 12, 2010) -

SAN FERNANDO, CA--(Marketwire - March 11, 2010) -  Precision Dynamics Corporation (PDC), the global leader in healthcare identification solutions, announced today that it has revitalized its brand to help redefine its offering to the clinician and patient experience. As part of this initiative, the company's new branding highlights its unique customer benefits that set it apart from other healthcare ID companies.

NEW YORK, NY--(Marketwire - March 11, 2010) -  The majority of new cancer tests coming to market are proprietary assays with the test services being provided by certified labs opened by the IVD companies that developed the tests. All the major reference labs in North America and Europe are also offering a slew of in-house developed diagnostic tests. This shift is leading to greater profits for those companies offering test services, notes healthcare market research publisher Kalorama Information in its new report "The Worldwide Market for Cancer Diagnostics, 4th Edition."

Acting CEO Dr. Charles Dinarello to Be Awarded Paul Ehrlich Prize

The Ruth Group Retained as Investor Relations Counsel

ORLive -- Your Destination for Live and On-Demand Surgery Video

BOSTON, MA--(Marketwire - March 11, 2010) -  A growing volume of global drug development and commercialization activity during the past decade has dramatically increased the workload for regulatory affairs professionals at pharmaceutical and biotech companies, according to a study recently completed by the Tufts Center for the Study of Drug Development.

XI'AN, CHINA--(Marketwire - March 11, 2010) -  Skystar Bio-Pharmaceutical Company (NASDAQ: SKBI) ("Skystar" or the "Company"), a China-based manufacturer and distributor of veterinary medicines, vaccines, micro-organisms and feed additives, today announced it has retained Grayling to provide the Company with financial communications support for its global investor relations program.

SAN DIEGO, CA--(Marketwire - March 11, 2010) - Entest BioMedical, Inc. (OTCBB: ENTB) announced today its CEO David Koos addressed the Company's shareholders and other interested parties on its new blog site. Topics covered in the interview included progress in the Stem Cell / Photoceutical treatment for COPD, immunotherapeutic cancer vaccine, potential grant funding and anticipated revenue sources for the Company. This interview may be heard on the Company's blog site, www.entestbioblog.com/live.

DUBLIN, IRELAND--(Marketwire - March 11, 2010) - Trinity Biotech plc (NASDAQ: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended December 31, 2009 and the disposal of its coagulation business to the Stago Group.

MALVERN, PA--(Marketwire - March 11, 2010) - Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, today announced the managed distribution network partners that have been contracted to support XIAFLEXT (collagenase clostridium histolyticum), a novel, first-in-class biologic for the treatment of adult Dupuytren's contracture in patients with a palpable cord.

BASEL, SWITZERLAND--(Marketwire - March 11, 2010) -

BIOLASE Announces Preliminary 2009 Fourth Quarter Results

ZWIJNAARDE, BELGIUM--(Marketwire - March 10, 2010) - Regulated information

Improved Security in the World's Ports Begins in Tennessee

BIOLASE to Host Conference Call, March 18th at 11:00 a.m. E.D.T.

Broadcast to Start at 2 p.m. EST Today

IRVINE, CA--(Marketwire - March 10, 2010) -  The Second International Cystinosis Research Symposium for scientists and researchers will be held April 8-9 at the Arnold and Mabel Beckman Center of the National Academies of Sciences and Engineering, adjacent to the University of California, Irvine.

NEW YORK, NY--(Marketwire - March 10, 2010) -  Glycated hemoglobin (HbA1c) testing is one of the success stories of point-of-care diagnostics, and an area that will experience higher growth rates than other POC tests as a result of expert recommendations, new cases and booming mail-in test sales, according to the new report "Point-of-care Diagnostics 2010 and Beyond: Rapid Testing at a Crossroads," by healthcare market research publisher Kalorama Information.

2 Independently Operating Refrigeration Systems for Failsafe Protection of Sensitive Samples

COLUMBIA, SC--(Marketwire - March 10, 2010) -  BDI Pharma, Inc. (BDI), the fastest growing national distributor of biotech therapies, recognized two distinct milestones during the first quarter of 2010 -- 15 years in business and the first anniversary of the organization's re-branding. BDI was founded on January 27, 1995 as Blood Diagnostics, Inc. focusing primarily upon products that comprise the plasma derivative and recombinant pharmaceutical market. In the latter half of 2007, the process of significantly expanding the company's portfolio began. The success of this expansion ultimately resulted in the organization's re-branding to better reflect the breadth of the specialty biopharmaceuticals offered. On February 2, 2009, BDI Pharma, Inc. officially became the corporation's new name. To make the transformation complete, the organization began operations in its new corporate headquarters on that very same day.

MCHENRY, IL--(Marketwire - March 10, 2010) -  Aventura Equities, Inc. (PINKSHEETS: AVNE) has acquired a majority interest in Renewed World Energies, Inc. of Georgetown, South Carolina, thereby shifting its focus to the alternative energy sector in a very significant corporate move. Directly related to the acquisition, Richard Armstrong, Tim Tompkins and Richard von Gnechten, have replaced the Board of Directors of Aventura Equities. Mr. Armstrong will assume the Chief Executive Officer position, while Mr. Francis Manzo will operate Wintree Corporation. A company 49% controlled by Aventura Equities, Inc.

Storage Experts to Discuss Challenges and Solutions for High-Throughput Sequencing and Next-Generation Cloud Storage Initiatives

CAMBRIDGE, UK--(Marketwire - March 10, 2010) -  CambridgeSoft today announces that VIB, a Belgium based non-profit life sciences research institute, has selected CambridgeSoft's E-Notebook for deployment to over 400 VIB researchers. This decision follows a successful pilot study carried out in 2009. E-Notebook, an application which facilitates research collaboration and knowledge management, will be rolled out during 2010 to VIB scientists active in many biotechnology research domains (genomics, plant biology, neurobiology, microbiology, etc) at four different universities in Flanders. 

ANN ARBOR, MI--(Marketwire - March 10, 2010) -  MichBio, the association for Michigan biosciences, will for the first time host its Annual Business Meeting and Showcase in Grand Rapids. The event will be held at Grand Valley State University's Eberhard Center on April 21 and feature a strolling dinner amid bioscience-related company exhibits from 5-7 p.m., followed by a keynote address by Mark B. Leahey, president and CEO of the Medical Device Manufacturers Association. The Medical Device Manufacturers Association (MDMA) is a national trade association based in Washington, DC, that represents research-driven medical technology companies.

JOHANNESBURG, SOUTH AFRICA--(Marketwire - March 10, 2010) -  www.rothmanresearch.com

MOUNTAINSIDE, NJ--(Marketwire - March 10, 2010) -  Proteonomix, Inc. (PINKSHEETS: PROT) announces that its wholly-owned subsidiary, Proteonomix Regenerative Translational Medicine Institute, Inc. ("PRTMI"), has created a subsidiary, PRTMI RD S.R.L., a corporation organized under the laws of the Dominican Republic ("DR").

REHOVOT, ISRAEL--(Marketwire - March 10, 2010) - Evogene Ltd. (TASE: EVGN) announced today its financial results for the fourth quarter and year ended December 31, 2009.

PHILADELPHIA, PA--(Marketwire - March 10, 2010) -  Eurand N.V. (NASDAQ: EURX), a global specialty pharmaceutical company, announced today that it is scheduled to present at the upcoming Barclays Capital 2010 Global Healthcare Conference. Gearóid Faherty, Eurand's Chairman and Chief Executive Officer, will be presenting.

Agreement Aligns AspenBio With a Leading OEM Provider of Lateral Flow Assays and Completes the Supply Chain for Commercial Production of the AppyScore(TM) Test

Australian Patent Provides Broad Protection of its Small Molecule Drug Candidates

Dr. Bogin Is an Expert in Stem Cell Clinical Trials and the CEO of Cromos Pharma LLC; Company Sees Addition Aiding Clinical Trials Development for COPD Stem Cell Treatment Model

SOUTH SAN FRANCISCO, CA--(Marketwire - March 10, 2010) - Cytokinetics, Incorporated (NASDAQ: CYTK) announced today that its fast skeletal muscle troponin activator, CK-2017357, has been granted orphan-drug designation by the U.S. Food and Drug Administration (FDA) for the potential treatment of amyotrophic lateral sclerosis (ALS), also commonly known as Lou Gehrig's Disease. CK-2017357 is the lead drug candidate that has emerged from the company's skeletal sarcomere activator program. Cytokinetics plans to initiate a Phase II Evidence of Effect clinical trial for CK-2017357 in ALS patients in the first half of 2010.

CHERRY HILL, NJ--(Marketwire - March 9, 2010) -  The Multiple Sclerosis Association of America (MSAA) encourages everyone to take time this March to learn about multiple sclerosis (MS) and discover all of the programs and services MSAA offers to everyone affected by MS.

FAIRFIELD, CA--(Marketwire - March 9, 2010) -  ChemSW, Inc. today announced the release of a new in-depth white paper that examines best practices for effectively controlling and reporting chemical inventory. Titled "How to Gain Complete Control of Your Chemical Inventory," the white paper provides tips and techniques for ensuring that chemical inventory is managed in a safe, efficient and cost-effective manner.

MANASSAS, VA--(Marketwire - March 9, 2010) -  Emerging World Pharma Inc. (PINKSHEETS: EWPI), an investor in generic based pharmaceutical companies manufacturing within developing nations, has provided an initial investment into a private generic pharmaceutical company located in West Africa. The investment would entitle Emerging World Pharma a percentage of profits obtained from an exclusive marketing and distribution agreement of generic pharmaceuticals. In addition the company has negotiated an option that would considerably increase the percentage of returns on profit with ongoing investments.

Nearly 200 Attendees and 40 Innovative Presenting Companies Along With a Dozen Sponsors Convened Last Week in Las Vegas

WEST PALM BEACH, FL--(Marketwire - March 9, 2010) - HearUSA, Inc. (NYSE Amex: EAR), a leader among the nation's hearing care providers, has been invited to present at the ROTH Capital Partners 22nd Annual OC Growth Stock Conference to be held at The Ritz Carlton in Dana Point, CA on March 15-17, 2010.

Objectif : amasser 50 000 $ pour les athlètes paralympiques du Canada en mars 2010

Sets goal to raise $50,000 for Paralympians this March 2010

Largest Promotion in Company's History Yields Bonuses Exceeding 250,000 USD

JERSEY CITY, NJ--(Marketwire - March 9, 2010) -  QUMAS, the leading provider of Compliance Solutions to highly regulated companies, has won the Deloitte Best Managed Companies Award.

Ingeniux Will Power Over 30 Global Websites and Automate Compliance Safeguards

BUFFALO, NY--(Marketwire - March 9, 2010) -  Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that the Company is scheduled to present at the Roth Capital Partners 22^nd Annual OC Growth Stock Conference, March 15-17, in Laguna Niguel, CA.

FORT LAUDERDALE, FL--(Marketwire - March 9, 2010) - OmniComm Systems, Inc. (OTCBB: OMCM), a global provider of eClinical solutions, announced today that a leading cardiovascular medical device manufacturer has renewed its contract with the company for another 5 years. The agreement extends and expands the previous five-year agreement which generated over $2.5 Million in revenue for the company over the past three years. The company expects revenue for this customer to increase.

Scientific Bio-Logics Welcomes iogen

SEATTLE, WA--(Marketwire - March 9, 2010) - HQ Sustainable Maritime Industries, Inc. (NYSE Amex: HQS) ("HQS" or the "Company"), a leading producer of functional, sustainable Tilapia biomass, including fish and personal healthcare products, will announce results for the fourth quarter ended December 31, 2009 on Monday, March 15, 2010, after market close. The Company will also host a conference call to discuss these results with additional comments and details. Participating on the call will be Norbert Sporns, President and Chief Executive Officer, and Jean-Pierre Dallaire, Chief Financial Officer.

ROCKVILLE, MD--(Marketwire - March 9, 2010) -  MarketResearch.com has announced the addition of GBI Research's new report "Stem Cell Research -- Market Trends, Investment Trends and Pipeline Analysis," to their collection of Stem Cell market reports. For more information, visit http://www.marketresearch.com/redirect.asp?progid=67618&productid=2584292.

Two New Programs Unveiled to Help Patients "Give Back"

Dramatic Performance and Usability Improvements Provide Access to Broader Range of Real World Behaviors

BOTHELL, WA--(Marketwire - March 9, 2010) -  AVI BioPharma, Inc. (NASDAQ: AVII), a developer of RNA-based drugs, will report fourth quarter and full year 2009 financial results before the NASDAQ Global Market opens on Tuesday, March 16, 2010. Subsequently, at 8:30 a.m. Eastern time (5:30 a.m. Pacific time), Dr. Leslie Hudson, AVI's President and Chief Executive Officer, and J. David Boyle II, AVI's Senior Vice President and Chief Financial Officer, will host a conference call to discuss the fourth quarter and full year 2009 financial results and to provide a corporate update.

Order Equips First Responders in Hollywood Entertainment Hub With Tools to Protect Community From Bioterrorism Attack

Palomar's Emphasis Will Be on Its Model 8000 Wire Bonder/Ball (Stud) Bumper's Versatility, With a Method That Enables Higher Density Packages

BURBANK, CA--(Marketwire - March 8, 2010) -  Imaging3T, Inc. (OTCBB: IMGG), developer of a breakthrough medical imaging device that produces 3D medical diagnostic images of virtually any part of the human body in real-time, announced today that on Wednesday, March 10, 2010 at 1:00pm PST, (4:00pm EST) the company's CEO, Mr. Dean Janes, will be hosting a conference call. To join the conference call, please call 1-888-732-6202 and enter passcode 745546 followed by the pound sign (#). You will be connected to the conference call in a listen only mode, and then lines will be opened for questions following the presentation.

PALATINE, IL and BRISTOL, TN--(Marketwire - March 8, 2010) -   Acura Pharmaceuticals, Inc. (NASDAQ: ACUR) and King Pharmaceuticals, Inc. (NYSE: KG) today announced top-line results from Study AP-ADF-114 ("Study 114") titled "A Randomized, Double-Blind, Placebo- and Active-Controlled Study to Assess the Relative Abuse Potential of Acurox^® (oxycodone HCl and niacin) Tablets in Non-Dependent Recreational Opioid Users." Study 114 top-line results demonstrate that two different potentially abused excess oral doses of Acurox^® Tablets are significantly disliked compared to equivalent excess oral doses of oxycodone HCl tablets alone (without niacin). All five co-primary endpoints comparing the like/dislike of excess doses of Acurox^® Tablets with the like/dislike of excess doses of oxycodone HCl tablets

NEW YORK, NY--(Marketwire - March 8, 2010) -  NewCardio, Inc. (OTCBB: NWCI) announced today that CEO, Dr. Branislav Vajdic, was interviewed on CorporateProfile.com.

SALT LAKE CITY, UT--(Marketwire - March 8, 2010) - El sábado 27 de febrero, uno de los terremotos más grandes en la historia azotó el país de Chile. El terremoto tuvo una magnitud de 8.8 en la escala de Richter y causó un tsunami que devastó las comunidades de la costa al sur de la capital de Santiago de Chile.

SALT LAKE CITY, UT--(Marketwire - March 8, 2010) -  On Saturday, February 27, one of the largest earthquakes in recent history hit the country of Chile. The quake measured 8.8 on the Richter scale and set off a tsunami that devastated coastal communities south of the capital, Santiago.

LONDON--(Marketwire - March 8, 2010) -

Smith and Nephew Continues to Deliver its Strategic Priorities

Company to introduce new and innovative products at the American
Academy of Orthopaedic Surgeons 2010 Annual Meeting in New Orleans

Representatives from across the business to attend

London, United Kingdom, March 8, 2010 - Smith & Nephew plc (LSE: SN,
NYSE: SNN), the global medical technology business, continues to
deliver on its strategic priorities by introducing new and innovative
products from its Orthopedics and Endoscopy business units at this
yearOs American Academy of Orthopaedic Surgeons ("AAOS") Annual
Meeting. Smith & Nephew's presence at this year's Annual Meeting will
feature the launch of several new products, as well as advances in
Smith & Nephew's current portfolio, and representatives from Smith &
Nephew Orthopaedic's medical education platform, KLEOS, will be on
hand. The combined success of Smith & Nephew's Orthopae					

The Nation's Largest Distributor of Critical-Care Biopharmaceuticals Announces Its Participation in National Patient Safety Awareness Week; the Company Will Launch a Multi-Faceted Campaign Aimed at Empowering Patients to Become Involved in Their Own Healthcare

SOUTH PLAINFIELD, NJ--(Marketwire - March 8, 2010) - GENEWIZ, Inc., a leading provider of DNA services, announced the expansion of its molecular biology portfolio with the addition of Gene Synthesis services. Gene synthesis provides researchers with a time- and cost-saving alternative to molecular cloning, DNA engineering, protein engineering and directed evolution for custom construct production.

BAGSVAERD, DENMARK--(Marketwire - March 8, 2010) -

Walk Now for Autism Speaks, April 24, Pasadena Rose Bowl

LEIDEN, NETHERLANDS--(Marketwire - March 8, 2010) -

DANVILLE, CA--(Marketwire - March 8, 2010) -  S3 Investment Company, Inc. (PINKSHEETS: SIVC) today announced that the company's Redwood Medical subsidiary, which distributes Western medical technologies and products into the China market, is currently working on additional State Food and Drug Administration (SFDA) approvals for the first product it has signed to distribute in China. 

World Glaucoma Week Raises Global Awareness of the Importance of Eye Health

BOTHELL, WA--(Marketwire - March 8, 2010) -  MDRNA, Inc. (NASDAQ: MRNA), a leading RNAi-based drug discovery and development company, today announced that J. Michael French, MDRNA's President and Chief Executive Officer, will provide an overview of the Company and its progress in key programs at the following upcoming conferences:

HIGH SPRINGS, FL--(Marketwire - March 8, 2010) -  CTD Holdings, Inc. (OTCBB: CTDH) (FRANKFURT: CDJ) today announced its plans to move the company's Aquaplex® product line out of the CTD, Inc. division and into NanoSonic Products, Inc. (NSP). The decision was made as a result of a successful orphan drug application filing made to the U.S. Food and Drug Administration for Trappsol® CycloT (hydroxypropyl beta cyclodextrin) in the treatment of Niemann Pick Type C disease.

To Serve as Platform for Screening of Regenerative Photoceuticals

MALVERN, PA--(Marketwire - March 8, 2010) - Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, today announced that XIAFLEXT (collagenase clostridium histolyticum), a novel, first-in-class, orphan-designated, biologic, is now available by prescription in the United States for the treatment of adult Dupuytren's contracture patients with a palpable cord.

SAN DIEGO, CA--(Marketwire - March 8, 2010) - Cypress Bioscience, Inc. (NASDAQ: CYPB) today announced that Sabrina Martucci Johnson, its Chief Operating Officer and Chief Financial Officer, will present at the Cowen and Company 30^th Annual Health Care Conference on March 10, 2010.

GLOSTRUP, DENMARK--(Marketwire - March 8, 2010) -